Received Jan 12, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
Drug Reactions/Allergies HEPATITUS VACCINE; Information has been received from Business Partner/CRO on 12-Dec-2025. This spontaneous report was received from a/an Consumer or other non health professional and refers to a(n) 73-year-old male patient. The patient's medical history was not reported. The patient's concurrent conditions included Drug Reactions/Allergies Neomycin. Historical drugs included Neomycin sulfate (Neomycin sulfate). Concomitant therapies were not reported. On an unknown date, the patient started therapy with unknown dosage. On an unknown date, the patient started therapy with Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB), (lot # and expiration date were not reported). On an unknown date, the patient started therapy with Hepatitis A Vaccine, Inactivated (lot # and expiration date were not reported). The patient started therapy with Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB), for the treatment of prophylaxis. The patient started therapy with Hepatitis A Vaccine, Inactivated for the treatment of p[rophylaxis. The patient started therapy with for the treatment of prophylaxis. On an unknown date, the patient experienced Drug Reactions/Allergies HEPATITUS VACCINE. At the reporting time, the outcome of Drug Reactions/Allergies HEPATITUS VACCINE was unknown. The action taken with Hepatitis B Vaccine (Recombinant) and Hepatitis A Vaccine, Inactivated was reported as not applicable. The reporter considered the event of Drug Reactions/Allergies HEPATITUS VACCINE to be related to Hepatitis B Vaccine (Recombinant). The reporter considered the event of Drug Reactions/Allergies HEPATITUS VACCINE to be related to Hepatitis A Vaccine, Inactivated.
Drug hypersensitivity